Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

(+)-BORNEOL

SKU: orb1301541

Description

(+)-Borneol is a bicyclic monoterpene utilized in traditional medicine for its analgesic and anesthetic properties. Research indicates it acts as a positive allosteric modulator of GABA_A receptors, with an EC50 of 248 μM, supporting its study in neuropharmacology and for potential therapeutic applications.

Research Area

Metabolism Research, Neuroscience, Pharmacology & Drug Discovery

Images & Validation

−
(+)-BORNEOL

Key Properties

−
CAS Number464-43-7
MW154.25
Purity99.60% (May vary between batches)
FormulaC10H18O
SMILESCC1(C)[C@@H]2CC[C@@]1(C)[C@@H](O)C2
TargetEndogenous Metabolite,GABA Receptor
SolubilityDMSO:247.5 mg/mL (1604.54 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (25.93 mM)

Bioactivity

−
Target IC50
GABA:248 μM(EC50)
In Vivo
(+)-borneol (1.0 mg/kg) significantly ameliorated infarct size and neurological scoresvia reducing the expression of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha (TNF-α) in a dose dependent manner. Notably, (+)-borneol showed long-term effects on the improvement of sensorimotor functions in the photothrombotic model of stroke, which decreased the number of foot faults in the grid-walking task and forelimb asymmetry scores in the cylinder task, at least in part through reducing loss of dendritic spines in the length, brunch number and density. Suggest that (+)-borneol could serve as a therapeutic target for ischemic stroke.
In Vitro
Aβ-induced cell cytotoxicity was inhibited by 100 μM of (-) and (+) borneol treatment. Treatment of borneol significantly decreased ROS generation (P < 0.01). The expression of HO-1 and nuclear translocation of Nrf2 were increased by Aβ treatment. This nuclear translocation of Nrf2 was further increased by administration of borneol. Compared with the Aβ treated group, the (+) borneol treated group significantly increased Bcl-2 expression with decreased expression of Bax.
Cell Research
Oxidative stress was induced by administering 50 μM Aβ into SH-SY5Y cells. Neuroprotective effect of commercially available borneol was examined by determining cell viability with the MTT assay. Intracellular reactive oxygen species (ROS) generation was measured using a fluorometer with further examination of heme oxygenase-1 (HO-1) and nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) expression. Apoptosis was examined by measuring the ratio of B-cell lymphoma 2 (Bcl-2)/Bcl-2-associated X protein (Bax).
Animal Research
To mimic a typical human stroke, which does not undergo reperfusion, used a permanent MCAO in this study. For investigating the role of (+)-borneol in permanent cerebral ischemia, 45 male Sprague-Dawley rats were randomly divided into the sham group, the vehicle-treated group and the (+)-borneol-treated groups (1.0 mg/kg), with 15 rats in each group. The terminal half-life (t1/2) of borneol was 2 h following cerebral ischemia-reperfusion. We subjected the rats to pMCAO and administered drugs by tail intravenous injection 2 hours and 5 hours after pMCAO, respectively. The sham group and the vehicle-treated group were injected with vehicle administration. Neurologic scores were assessed at 48 hours after reperfusion.

Storage & Handling

−
Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

−
GABA, GABA Receptor, GABAReceptor, BORNEOL, (+) BORNEOL, (+)BORNEOL, d-Borneol

Similar Products

−
  • Borneol

    Borneol [orb422186]

    > 98%,Standard References

    507-70-0

    154.25

    C10H18O

    20 mg
  • （+）-Borneol

    （+）-Borneol [orb703771]

    98.5%（GC）

    464-43-7

    50 mg
  • (-)-borneol

    (-)-borneol [orb1303818]

    99.69% (May vary between batches)

    464-45-9

    154.25

    C10H18O

    1 ml x 10 mM (in DMSO), 100 mg
  • L-Borneol 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside

    L-Borneol 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside [orb1684729]

    99.28% (May vary between batches)

    88700-35-0

    448.50

    C21H36O10

    5 mg
  • Xanthoxylin

    Xanthoxylin [orb1304775]

    >99.99% (May vary between batches)

    90-24-4

    196.2

    C10H12O4

    1 g, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID
6552009 ↗

Key Properties

−
No computed properties available.

Protocol Information

Find More Protocols

Available Sizes

Select a size below

50 mg
$ 90.00
1 ml x 10 mM (in DMSO)
$ 90.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry
Need technical support? Find your Distributor Return and Tax Policy

Email

info@biorbyt.com

UK Office

+44 (0)1223 859353

US Office

+1 (415) 906-5211

CN Office

+86 (27)-87663101

Distributors

biorbyt.com/distributor